NRT Smoking Cessation Aids in Australia

NRT Smoking Cessation Aids in Australia

Overall demand for NRT smoking cessation aids in Australia remains above pre-pandemic levels, in line with an ongoing fall in smoking prevalence among adult smokers. According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey 2022-2023, fewer than 10% of people in Australia over 14 years of age smoked daily, while the use of e-vapour products tripled between 2019 and 2022-2023.The proportion of those who smoke daily has dropped by two thirds from 24% in...

Euromonitor International's NRT Smoking Cessation Aids in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.